DKC1 Antibody - BSA Free

Western Blot: DKC1 Antibody [NBP1-85156]

Western Blot: DKC1 Antibody [NBP1-85156] - Lane 1: Marker [kDa] 206, 113, 82, 49, 32, 26, 18 Lane 2: Human cell line RT-4 Lane 3: Human cell line U-251MG sp Lane 4: Human cell line A-431 Lane 5: Human liver tissue Lane 6: Human tonsil tissue

Immunohistochemistry-Paraffin: DKC1 Antibody [NBP1-85156]

Immunohistochemistry-Paraffin: DKC1 Antibody [NBP1-85156] - Staining of human cerebral cortex shows strong nucleolar positivity in neuronal cells.

Immunohistochemistry: DKC1 Antibody - BSA Free [NBP1-85156] -

Distinct immune microenvironments exist in CI and CII. (a) Comparisons of Lymphocytes Fraction (see Section 4) between two clusters in two CRC databases by different immune faction analysis, xcell, and ESTIMATE [31,32]. (b) Comparisons of Macrophages between two clusters in 2014 CPTAC CRC databases analyzed by three methods, xcell, CIBERSORT, and immune staining of CRC databases [31,33,34]. (c) Comparisons of Monocytes between two clusters in 2019 CPTAC CRC Label free databases analyzed by xcell. (d) The distribution of patients belonging to two clusters in four different immune subtypes from Thorsson et al., 2018, Immunity [35]. (e) Scatter diagram showing correlations of DKC1 protein expression with CD8+ Tcm cells in total patients in 2014 CPTAC CRC databases. (f) Scatter diagram showing correlations of DKC1 protein expression with CD8+ Tcm cells in CI or CII cluster in 2014 CPTAC CRC databases. (g) Representative images of DKC1 immunochemistry staining and CD8+ T cells in colorectal cancer tissues. (h) Spearman correlation of DKC1 expression with CD8+ T cells in invasive front (where tumor invaded normal lamina propria) in colorectal cancer. (i) The relative DKC1 and CD8 expression of patients in Immunohistochemical high and low score groups (divided by median expression) (* p < 0.05, ** p < 0.01, *** p < 0.001, error bar indicates +/-SEM). (j) Volcano plot showing immunomodulators’ proteomics in CII versus CI in two CRC proteomics databases. Blue indicates Log2 (fold change (CII/CI) > 0.5, p < 0.05) [35]. (k) The boxplot showing the mRNA expressions of immunomodulators in 2014 and 2019 CRC databases. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36428700), licensed under a CC-BY license. Not internally tested by Novus Biologicals.